What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
CMA Advocates Non-Compete Clause Reform and Salary Threshold Ban
The UK's Competition and Markets Authority (CMA) has responded to a government working paper on reforming non-compete clauses in employment contracts. The CMA advocates for reforms, including a ban on non-competes below a salary threshold, to enhance labour market mobility.
FCA Stablecoin Regulatory Sandbox Testing
The FCA has selected four firms to participate in its regulatory sandbox to test stablecoin innovation. This initiative aims to gather real-world data to inform the development of future UK stablecoin regulations, with findings expected to shape final rules later in 2026.
Payments Forward Plan Published by Committee
The Payments Vision Delivery Committee, comprising HM Treasury, Bank of England, FCA, and PSR, has published the Payments Forward Plan. This plan outlines upcoming initiatives in retail and wholesale payments, including digital assets, to foster innovation and economic growth.
CMA Investigates ABF Acquisition of Hovis Merger
The UK's Competition and Markets Authority (CMA) has launched an investigation into the anticipated acquisition of Hovis Group Limited by Associated British Foods plc. The inquiry is currently in Phase 2, with a statutory deadline of June 24, 2026.
CMA Investigates Hays Travel Merger
The UK's Competition and Markets Authority (CMA) has launched merger inquiries into Hays Travel's acquisitions of Polka Dot Travel and Millington Travel. Initial enforcement orders have been served, and phase 1 decision deadlines are set for April 2026.
Homes England Subsidy Referral for 2020 Developments Luton
The UK's Competition and Markets Authority (CMA) has published its final report advising Homes England on a proposed £29.5 million subsidy to 2020 Developments (Luton) Limited. This subsidy is for infrastructure development to unlock residential and employment space.
CMA Merger Inquiry: LDC acquires Green Label
The CMA has opened a merger inquiry into the acquisition of Green Label Holdings Limited by Société LDC SA. An initial enforcement order has been served, and an invitation to comment is open until March 9, 2026, to gather views on potential competition impacts.
Post Office Subsidy Scheme Report and Consultation
The CMA's Subsidy Advice Unit has accepted a request for a report on the proposed £609.2m Post Office Transformation Subsidy Scheme. The Department for Business and Trade is seeking advice on compliance with subsidy control requirements. Comments are due by March 11, 2026.
EMA Recommends Six New Medicines for Approval
The European Medicines Agency's CHMP has recommended six new medicines for marketing authorisation and nine for extension of therapeutic indications. These recommendations cover treatments for various conditions including menopausal symptoms, liver disease, a rare genetic disorder, influenza, and graft-versus-host disease.
EMA Recommends Kygevvi for Rare TK2d Disease Treatment
The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Kygevvi, a new treatment for the rare genetic disease thymidine kinase 2 deficiency (TK2d). This recommendation is based on clinical study data showing improvement in motor function for pediatric patients.
Browse by category
US Federal
932 sources
US State
116 sources
US Courts
122 sources
UK
61 sources
EU
53 sources
Canada
23 sources
Government & Legislation
240 sources
Courts & Legal
210 sources
Banking & Finance
179 sources
Trade & Sanctions
122 sources
Labor & Employment
107 sources
Healthcare
106 sources
Energy
94 sources
Environment
81 sources
Securities & Markets
73 sources
Pharma & Drug Safety
68 sources
Agriculture & Food Safety
61 sources
Data Privacy & Cybersecurity
59 sources
Transportation
56 sources
Defense & National Security
48 sources
Tax
48 sources
Consumer Protection
35 sources
Telecom & Technology
34 sources
Education
20 sources
Insurance
17 sources
Housing
15 sources
Immigration
8 sources
Browse by agency
State PUC
38 sources
State Health
38 sources
State DOR
36 sources
State Labor
32 sources
SEC
28 sources
State DEQ
25 sources
FDA
21 sources
State AG
17 sources
State Securities
17 sources
DOJ
13 sources
White House
13 sources
GSA
12 sources
BIS
12 sources
EC
11 sources
DOL
11 sources
USTR
11 sources
CBP
10 sources
CFPB
10 sources
USCIS
8 sources
Congress
7 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.